Enanta Pharmaceuticals (ENTA) Other Gross PP&E Adjustments: 2012-2025
Historic Other Gross PP&E Adjustments for Enanta Pharmaceuticals (ENTA) over the last 12 years, with Sep 2025 value amounting to $8.7 million.
- Enanta Pharmaceuticals' Other Gross PP&E Adjustments rose 246.00% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.9 million, marking a year-over-year increase of 231.53%. This contributed to the annual value of $8.7 million for FY2025, which is 246.00% up from last year.
- As of Q3 2025, Enanta Pharmaceuticals' Other Gross PP&E Adjustments stood at $8.7 million, which was down 55.37% from $19.6 million recorded in Q2 2025.
- Enanta Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $19.6 million during Q2 2025, with a 5-year trough of -$36.0 million in Q1 2024.
- Its 3-year average for Other Gross PP&E Adjustments is -$3.6 million, with a median of $2.5 million in 2024.
- Per our database at Business Quant, Enanta Pharmaceuticals' Other Gross PP&E Adjustments crashed by 277.02% in 2022 and then soared by 246.00% in 2025.
- Over the past 5 years, Enanta Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$19.4 million in 2021, then fell by 21.32% to -$23.5 million in 2022, then climbed by 9.33% to -$21.3 million in 2023, then soared by 176.98% to $16.4 million in 2024, then soared by 246.00% to $8.7 million in 2025.
- Its last three reported values are $8.7 million in Q3 2025, $19.6 million for Q2 2025, and $18.1 million during Q1 2025.